SPOC Proteomics, Inc, a deep-tech life sciences company based out of Scottsdale Arizona (HQ) and Menlo Park California, announced the commercial launch of their customizable sensor-integrated proteome on chip (SPOC®) biosensors for limited beta testing at SLAS2024.
GSK acquires autoimmune drug candidate
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning, it’s a busy